Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 31.05.2014

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
31.05.14FRC Responds to Reports Meriam Ibrahim May Be Released from Sudan's Death Row, Urges Safe Haven in U.S.170WASHINGTON, May 31, 2014 /PRNewswire-USNewswire/ --Family Research Council President (FRC) Tony Perkins responded today to reports that the Sudan government may release Meriam Ibrahim from death row...
► Artikel lesen
31.05.14Foresters, KaBOOM! and volunteers bring families together with new playground in Greensboro150Playground will enhance family and community well-being GREENSBORO, NC, May 31, 2014 /PRNewswire/ - The Greensboro community was revitalized today thanks to a new playground built at Camp Weaver....
► Artikel lesen
31.05.14Foresters, KaBOOM! and volunteers bring families together with new playground in Prince George's County156Playground will enhance family and community well-being LANHAM, MD, May 31, 2014 /PRNewswire/ -Prince George's County community was revitalized today thanks to a new playground built at Seabrook...
► Artikel lesen
31.05.14Markey Addresses Bunker Hill Community College Commencement Exercises175BOSTON, May 31, 2014 /PRNewswire-USNewswire/ --U.S. Senator Edward J. Markey delivered the keynote address today at the 40th Commencement exercises at Bunker Hill Community College (BHCC). A record-breaking...
► Artikel lesen
31.05.14Positive Data from Phase 2 Trial of Nektar Therapeutics' NKTR-102 in Patients with Avastin-Refractory High-Grade Glioma Presented at 50th ASCO Meeting189SAN FRANCISCO, May 31, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with...
► Artikel lesen
31.05.14Cash Store Financial Announces Cease Trade Order Issued by Alberta Securities Commission17EDMONTON, May 31, 2014 /PRNewswire/ - The Cash Store Financial Services Inc. ("Cash Store Financial" or the "Company") announced today that a Cease Trade Order (the "Cease Trade Order") was issued...
► Artikel lesen
31.05.14Ronald McDonald House Charities Of Southern California Helps High School Seniors Fund Their Higher Education By Awarding $338,000 In College Scholarships25LOS ANGELES, May 31, 2014 /PRNewswire/ -- Today, Ronald McDonald House Charities® (RMHC) of Southern California awarded $338,000 in scholarship funds to 111 exceptional high school seniors from Los...
► Artikel lesen
31.05.14Benzene Consumption Market worth 53,432.9 Kilotons by 201825DALLAS, May 31, 2014 /PRNewswire/ -- The report"Benzene Market & Its Derivatives(Ethylbenzene, Cumene, Cyclohexane, Nitrobenzene, and Alkylbenzene) Market by Application & Geography-Trends and Forecasts...
► Artikel lesen
31.05.14Statewide Charter School Movement Mobilizes Unprecedented Strength To Preserve, Promote Quality Schools In Illinois78CHICAGO, May 31, 2014 /PRNewswire-USNewswire/ -- With the conclusion of the 2014 Illinois legislative session just minutes ago, the Illinois Network of Charter Schools (INCS) recognizes the leadership...
► Artikel lesen
31.05.14Investigational Drug AZD9291 Shows Clinical Responses in Patients With Advanced NSCLC Who Have Previously Failed on Established EGFR TKIs67CHICAGO, May 31, 2014 /PRNewswire/ -- Data from the ongoing Phase I AURA study in patients with epidermal growth factor receptor mutation positive (EGFRm+), advanced non-small cell lung cancer (NSCLC)...
► Artikel lesen
31.05.14Ooredoo Launches Global Campaign with Leo Messi31DOHA, Qatar, May 31, 2014 /PRNewswire/ -- Ooredoo today launch its first-ever global communication campaign with brand ambassador Leo Messi, as the company reaches out to football fans and social...
► Artikel lesen
31.05.14Barbie welcomes internationally renowned actress, Fan Bing Bing, to shine in her global Hall of Fame debut54SHANGHAI, May 31, 2014 /PRNewswire/ -- Launch of Barbie Fan Bing Bing Celebrity Specialty doll. She joins Barbie in inspiring young girls to "Shine Your Way". 2014 will marks the 55th anniversary...
► Artikel lesen
31.05.14Remember the Removal Bike Riders Retrace Cherokee History47CHEROKEE, N.C., May 31, 2014 /PRNewswire/ -- Six members of the Eastern Band of Cherokee Indians joined 12 members of the Cherokee Nation from Oklahoma in the annual 950-mile, "Remember the Removal"...
► Artikel lesen
31.05.14Amines Market, Phthalic Anhydride and Derivatives 2018 Forecasts27DALLAS, May 31, 2014 /PRNewswire/ -- RnRMarketResearch.com offers Amines Market By Type (Ethanolamines, Alkylamines, Fatty Amines, Specialty Amines And Ethylene Amines), By Application (Agricultural...
► Artikel lesen
31.05.14IMBRUVICA (ibrutinib) Combination with anti CD20 Antibody Shows Compelling Results in Heavily Pretreated Patients with CLL and Related Diseases25SUNNYVALE, Calif., May 31, 2014 /PRNewswire/ --Pharmacyclics, Inc. (NASDAQ: PCYC) announced today that IMBRUVICA®(ibrutinib) in combination with the anti-CD20 antibody, ofatumumab, showed a Kaplan...
► Artikel lesen
31.05.14IMBRUVICA (ibrutinib) Shows Durable, Long-Term Responses for Patients with CLL27SUNNYVALE, Calif., May 31, 2014 /PRNewswire/ --Pharmacyclics, Inc. (NASDAQ: PCYC) announced today that IMBRUVICA®(ibrutinib) will be featured in an oral presentation...
► Artikel lesen
31.05.14IMBRUVICA (ibrutinib) Significantly Improves Progression Free Survival, Overall Survival and Overall Response as compared to Ofatumumab in Patients with Previously Treated CLL/SLL in its First Phase III study21SUNNYVALE, Calif., May 31, 2014 /PRNewswire/ --Pharmacyclics, Inc. (NASDAQ: PCYC) today announced trial results of the first Phase III study (RESONATE, PCYC-1112-CA), a head-to-head comparison of...
► Artikel lesen
31.05.14PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2)38CHICAGO, May 31, 2014 /PRNewswire/ --Prometheus Laboratories Inc. announced today that data from the PROCLAIMSM national patient registry retrospective cohort document an improvement in median overall...
► Artikel lesen
31.05.14Castle Biosciences' Esophageal Cancer Test Accurately Predicts Pre-Surgical Treatment Response33CHICAGO, May 31, 2014 /PRNewswire/ --Castle Biosciences Inc. today announced study results from its proprietary multi-analyte test DecisionDx-EC, which is designed to determine which patients with...
► Artikel lesen
31.05.14Amgen Highlights Phase 2 Results Of Vectibix (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer41THOUSAND OAKS, Calif., May 31, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from the Phase 2 PEAK study that reinforce the improved overall survival (OS) benefit of panitumumab...
► Artikel lesen
Seite:  Weiter >>
Suchbegriffe der letzen 24 hAnzahl
EVOTEC7.846
TESLA5.693
NVIDIA3.487
TUI3.408
NEL2.820
VARTA2.767
SUPER MICRO COMPUTER2.626
BAYER2.263
RHEINMETALL2.173
DEUTSCHE BANK2.018
AIXTRON SE1.851
RENK GROUP1.836
INFINEON1.655
BYD1.492
PLUG POWER1.413
BASF1.392
DEUTSCHE LUFTHANSA1.342
COMMERZBANK1.273
SAP1.120
ALLIANZ1.096
RWE1.041
MERCEDES-BENZ1.021
THYSSENKRUPP1.005
NORDEX935
VOLKSWAGEN922